Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence

por Pandya, K, Meeke, K, Clementz, A G, Rogowski, A, Roberts, J, Miele, L, Albain, K S, Osipo, C
Publicado 2011